{"mainPropery":{"diseaseId":13003,"diseaseName":"Lupus erythematosus tumidus","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/13003/lupus-erythematosus-tumidus","synonyms":["Intermittent cutaneous lupus","Tumid lupus erythematosus"],"synonyms-with-source":[{"name":"Intermittent cutaneous lupus","source":"OrphaData.Org"},{"name":"Tumid lupus erythematosus","source":"Pubmed"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"90283"},{"identifierType":"ICD 10","identifierId":"L93.2"}]},"diseaseCategories":[{"diseaseTypeId":22,"diseaseTypeName":"Skin Diseases","source":"Orphanet"}],"organizations":[{"resourceID":247,"resourceName":"Lupus Foundation of America","abbreviation":"","address1":"2121 K Street, N.W.","address2":"Suite 200","address3":"","address4":"","address5":"","city":"Washington","state":"DC","zip":"20037 ","country":"United States","phone":"+1-202-349-1155 ","tty":"","tollFree":"1-800-558-0121","fax":"+1-202-349-1156 ","email":"info@lupus.org","url":"https://www.lupus.org/","freeText":""},{"resourceID":931,"resourceName":"Alliance for Lupus Research","address1":"28 West 44th Street","address2":"Suite 501","city":"New York","state":"NY","zip":"10036","country":"United States","phone":"212-218-2840","tollFree":"800-867-1743","fax":"","email":"info@lupusresearch.org","url":"http://lupusresearch.org/"},{"resourceID":3470,"resourceName":"Skin Support","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"http://www.skinsupport.org.uk/","freeText":""}],"resource descriptions":[{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=90283' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2162,"resourceId":3371,"resourceName":"The Assistance Fund","descriptionText":"<a href='https://tafcares.org/patients/covered-diseases/' target='_blank'>The Assistance Fund</a> provides various services, including education and financial aid, to help patients with a chronic or serious illness cover the cost of FDA-approved medications. Patients must be U.S citizens or permanent residents.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":10610,"questionText":"What is tumid erythematosus lupus?","answerText":"<strong>Tumid erythematosus lupus </strong>is considered a rare type of chronic cutaneous lupus erythematosus. <a href=\"http://www.americanskin.org/resource/lupus.php\" target=\"_blank\">Cutaneous lupus erythematosus</a> (CLE) can be divided into  <a href=\"http://www.dermnetnz.org/immune/cutaneous-lupus.html#a\" target=\"_blank\">acute cutaneous lupus</a>, <a href=\"http://www.dermnetnz.org/immune/cutaneous-lupus.html#s\" target=\"_blank\">subacute cutaneous lupus</a>, and <a href=\"http://www.dermnetnz.org/immune/cutaneous-lupus.html#c\" target=\"_blank\">chronic cutaneous lupus</a>.[11442] Tumid erythematosus lupus is characterized by smooth, non-scarring, pink- to violet-colored pimples (papules)&nbsp;on the skin without any other apparent skin changes, such as scarring. Patients with tumid lupus erythematosus usually do not have other symptoms of <a href=\"https://rarediseases.info.nih.gov/gard/10253/lupus/resources/1\" target=\"_blank\">systemic lupus erythematosus</a> or other types of cutaneous lupus erythematosus.[11441][11442] The papules appear on sun-exposed areas of the face, upper back, V area of the neck, trunk, and arms, and more rarely on thighs and legs. They usually affect equally both sides of the body, but may affect only one side. Normally, the papules clear without leaving scars.[11442] The treatment is very effective in most cases, and may include sun protection,&nbsp;<a href=\"http://www.cdc.gov/malaria/travelers/drugs.html\" target=\"_blank\">anti-malarials drugs</a>,&nbsp;<a href=\"http://www.dermnetnz.org/treatments/topical-steroids.html\" target=\"_blank\">local corticosteroids</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a602020.html\" target=\"_blank\">topical tacrolimus</a> and <a href=\"http://www.skinsight.com/cosmetics/phototherapy.htm?Imiw9cApl\" target=\"_blank\">light therapy</a>.[11441][11442][11444]","dateModified":"2016-05-02T17:47:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":6225,"relatedDiseaseName":"Cutaneous lupus erythematosus","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Lupus_erythematosus_tumidus"}